U.S. Infrastructure Stock News

Medpace Holdings has delivered a 203.1% return over the past 5 years, yet there is a clear valuation split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while earnings based multiples suggest the stock is trading at a premium. For investors, the tension is that the stock screens as mixed on broader valuation checks even as its recent share price performance has been strong. Over the past 5 years Medpace Holdings has returned 203.1%, which puts the current...

Gap (GAP) is back in focus after recent research coverage pointed to improving fundamentals, solid cash reserves, manageable debt, and an ongoing business transformation that drew a fresh Strong Buy rating from analysts. See our latest analysis for Gap. Gap's recent Strong Buy rating comes after a rough patch in the share price, with the stock down 23.58% based on year to date share price return and a 1 year total shareholder return decline of 12.83%, even though 3 year total shareholder...

Event driven focus on Aflac stock Aflac (AFL) recently filed an omnibus shelf registration covering common stock, debt securities, warrants, subscription rights, purchase contracts and purchase units, giving the company a flexible framework for potential future capital raising. This filing sits alongside upcoming earnings dates and recent cybersecurity disclosures. Investors are weighing how expanded financing capacity, operational updates and risk management could feed into Aflac stock’s...

Credo Technology Group Holding (CRDO) just moved into larger cap and growth focused Russell indices as it exited smaller benchmarks, coinciding with strong quarterly results and an upbeat fiscal 2027 revenue outlook. See our latest analysis for Credo Technology Group Holding. The shift of Credo Technology Group Holding into larger Russell indices follows strong AI connectivity headlines and a rapid share price run, with a 90 day share price return of 136.10% and a 1 year total shareholder...

Chagee Holdings stock has seen a steep share price decline over the past year, yet its valuation checks currently lean cheap, which sets up a clear tension between weak recent returns and what the broader metrics suggest about value. Over the last 1 year, Chagee Holdings is down 57.1%, which means anyone holding through that period has experienced a substantial drawdown. Future revenue and cash flow execution may support rebuilding confidence in the business, while any pressure on margins or...

Recent product moves at Fiserv (FISV), including embedding Personetics’ AI platform into its Experience Digital suite and partnering with Strivve on card-on-file automation, are drawing attention to how the stock reflects these shifts. See our latest analysis for Fiserv. Against this backdrop of AI-focused product moves, Fiserv’s share price has shown short term momentum, with a 1-day share price return of 3.15% and 7-day return of 5.82%. However, its 30-day and year to date share price...

Baker Hughes recently announced several sizeable energy contracts, including subsea production systems for Azule Energy’s Greater PAJ development in Angola and lifecycle turbomachinery services for Nigeria’s ANOH Gas Processing Plant. The company’s new geothermal partnership with Mantle Reach Power in North America underscores how its technology is being applied across both conventional and lower-carbon energy projects. Next, we’ll examine how Baker Hughes’ expanding subsea and geothermal...

With inflation trends diverging across regions, energy prices reacting to Middle East tensions, and central banks sending mixed policy signals, many investors are looking for assets tied to essential long term power demand rather than short term sentiment. Nuclear energy stocks sit at the crossroads of energy security and cleaner baseload power, attracting attention as countries reassess how they generate electricity. This Nuclear Energy Stocks screener filters companies across uranium...

AvePoint (AVPT) was added to the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index on 27 June 2026, an inclusion that can draw fresh attention from index-linked funds and institutional investors. See our latest analysis for AvePoint. AvePoint’s recent index inclusions come after a mixed share price record, with a 90 day share price return of 14.26% alongside a year to date share price decline of 13.31%, while the three year total shareholder return of 105.01% points to...

Riot Platforms (RIOT) has been added to multiple Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth, a move that can influence index driven ownership and trading activity. See our latest analysis for Riot Platforms. Riot Platforms has seen sharp swings recently, with the share price down 22.61% over the past week and 10.34% over the past month, yet still up 63.54% over 90 days and delivering an 81.68% total shareholder return over the past year. This points...

Coherent (COHR) has been caught in a broad pullback in high valuation AI infrastructure stocks, with shares dropping alongside optical and semiconductor peers even as its revenue growth and policy support headlines remain intact. See our latest analysis for Coherent. Coherent’s share price has pulled back sharply in the short term, with a 1 day share price return of 9.6% down and a 7 day return of 12.4% down. This has interrupted strong momentum that includes a 90 day share price return of...

Progyny (PGNY) has come into focus after being removed from the Russell 2000 Dynamic Index, an event that can prompt mechanical buying or selling as index trackers rebalance their portfolios. See our latest analysis for Progyny. Progyny's share price has been firming, with a 16.86% 1 month share price return and an 80.10% 3 month share price return. However, the 1 year total shareholder return of 40.82% contrasts with weaker 3 and 5 year total shareholder returns. If Progyny's recent index...

Tempus AI (TEM) drew fresh investor attention after announcing a collaboration with Angiosarcoma Awareness, Inc. focused on one of the largest molecular datasets for this rare cancer, tying its AI platform directly to high impact research. See our latest analysis for Tempus AI. Against this backdrop, Tempus AI’s recent research collaborations and validation work on its ECG-AF software have arrived during a period of strong momentum. The company has recorded a 30 day share price return of...

CNX Resources (CNX) has been removed from the Russell 2000 Dynamic Index, a change that can prompt index funds and some institutional investors to rebalance positions. This may affect liquidity and short term trading flows. See our latest analysis for CNX Resources. Against this index change backdrop, CNX Resources has seen its share price soften, with the 90 day share price return down 14.7% and the year to date share price return down 7.2%. However, the 5 year total shareholder return...

Investor interest in Cheniere Energy (LNG) is being shaped by a new engineering, procurement and construction contract with Bechtel for the SPL Expansion Project, tighter global LNG supply after Qatari outages, and higher full year guidance. See our latest analysis for Cheniere Energy. At a share price of $245.97, Cheniere Energy has a 1-month share price return of 2.99% and is up 24.35% year to date. The 5-year total shareholder return of 193.12% shows how earlier investors have been...

BXP (BXP) stock is in focus after the company signed a long term lease with Boston Dynamics for about 320,000 square feet at Reservoir Place in Waltham, Massachusetts. See our latest analysis for BXP. The Boston Dynamics agreement lands at a time when BXP’s share price has gained 11.21% over the past month and 33.56% over the past 90 days, while the 1 year total shareholder return stands at 5.20% and the 3 year total shareholder return is 37.82%. This suggests momentum has been building...

Short term Treasury yields above 4% and banks lifting deposit rates are putting cash and ultra short fixed income back in the spotlight. For investors weighing how to respond to higher yields and shifting expectations for Federal Reserve policy, a key question is which stocks are most exposed to these moves in short duration markets. This article looks at three stocks from a Short Term Fixed Income Opportunities screener that appear positively tied to this rate backdrop, helping you consider...

In late June 2026, PayPal’s shares were removed from the Russell Top 200 and Top 200 Value indices and added to the Russell Midcap and Midcap Value benchmarks, while the company also highlighted the performance of its Transaction Graph and Storefront Ads products for advertisers. By showcasing very large incremental advertising returns and new-customer gains for brands like Adorama, Best Buy, and Etsy, PayPal is positioning its transaction-level data as a differentiated asset beyond...

Kyndryl Holdings recently announced an expansion of its sovereignty solutioning with Microsoft, combining Kyndryl’s advisory and operational expertise with Microsoft’s Sovereign Cloud capabilities to help customers design, build and operate compliant cloud architectures across public Azure, Microsoft 365 and Azure Local private cloud deployments. An interesting aspect of this collaboration is Kyndryl’s Sovereignty Readiness Assessment, which translates complex regulatory frameworks into...

Fluor stock has delivered a very strong 187.3% return over the past 5 years, and the current valuation checks and recent share price pullback raise a question about how much upside may still be priced in. Over 5 years, Fluor has returned 187.3%, which puts recent short term weakness into the context of a long period of strong gains. Recent progress on large infrastructure and energy projects can support confidence in future cash generation, while execution risk on complex contracts and large...

In late June 2026, AbbVie reported multiple product wins, including new pediatric approvals for SKYRIZI, positive CHMP opinions for RINVOQ in alopecia areata and non-segmental vitiligo, and strong Phase 3 lymphoma data for epcoritamab plus lenalidomide versus R-GemOx. Together, these updates extend AbbVie’s immunology and oncology reach into earlier-stage, high-need patient groups, potentially deepening usage of its existing flagship therapies rather than relying solely on entirely new...

In late June 2026, Edwards Lifesciences announced new clinical data across its aortic, mitral and tricuspid portfolios at New York Valves 2026, while also being reclassified into several Russell midcap and defensive value indexes following its removal from the Russell Top 200 group. The fresh evidence around the PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and ENCIRCLE studies highlights how Edwards is aiming to broaden treatment options for complex structural heart disease patients beyond...

Tariff headlines can make it hard to judge which U.S. stocks might quietly benefit or face added friction. With Trump’s levies generating record government revenue while much of U.S. trade still enters duty free, the picture for consumer staples is more nuanced than it first appears. This article focuses on three large U.S. consumer staples stocks exposed to the latest tariff backdrop and explains how their essential goods focus, supply chains, and pricing power could shape the way they...

Nucor stock has delivered a strong 144.7% return over the past 5 years, yet current checks suggest the market price may still sit below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supporting multiples. That combination, alongside a mixed overall value score, puts the focus on whether the recent gains have already reflected the key fundamentals. Over 5 years, Nucor has returned 144.7%, which puts long term holders in a significantly stronger position than...